-
21
-
22
-
23
-
24
Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicado 2025Materias: -
25
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicado 2025Materias: -
26
Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicado 2025Materias: -
27
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicado 2025Materias: -
28
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicado 2025Materias: -
29
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Publicado 2025Materias: -
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40